Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) EBT: 2010-2025

Historic EBT for Exponent (EXPO) over the last 16 years, with Oct 2025 value amounting to $38.6 million.

  • Exponent's EBT rose 7.46% to $38.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $144.5 million, marking a year-over-year decrease of 1.10%. This contributed to the annual value of $147.4 million for FY2025, which is 8.44% up from last year.
  • Exponent's EBT amounted to $38.6 million in Q4 2025, which was up 4.89% from $36.8 million recorded in Q3 2025.
  • In the past 5 years, Exponent's EBT registered a high of $40.4 million during Q1 2024, and its lowest value of $19.6 million during Q1 2021.
  • Its 3-year average for EBT is $36.0 million, with a median of $36.3 million in 2023.
  • The largest annual percentage gain for Exponent's EBT in the last 5 years was 61.89% (2021), contrasted with its biggest fall of 8.42% (2021).
  • Quarterly analysis of 5 years shows Exponent's EBT stood at $28.7 million in 2021, then climbed by 6.50% to $30.5 million in 2022, then dropped by 1.41% to $30.1 million in 2023, then rose by 5.64% to $35.9 million in 2024, then climbed by 7.46% to $38.6 million in 2025.
  • Its EBT was $38.6 million in Q4 2025, compared to $36.8 million in Q3 2025 and $37.8 million in Q2 2025.